Thanks for the post. It's good to see justice prevail occasionally.
The sad thing is Rosen actually stated the cause of their investigation to be an article of the very same nature.
"On August 6, 2015, Seeking Alpha published an article revealing that Cellceutix misrepresented the efficacy of its drug candidates Brilacidin, Kevetrin, and Prurisol. On this news, shares of Cellceutix fell sharply during intraday trading on August 6, 2015, damaging investors."